AJP - Endocrinology and Metabolism, Vol 264, Issue 4 E561-E566, Copyright © 1993 by American Physiological Society

ARTICLES

Hepatic and extrahepatic insulin action in humans: measurement in the absence of non-steady-state error

H. Katz, P. Butler, M. Homan, A. Zerman, A. Caumo, C. Cobelli and R. Rizza
Department of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905.

The isotope dilution technique has been extensively used to assess insulin action in humans. To determine if nonsteady state (NSS) has led to erroneous estimates of hepatic and extrahepatic insulin sensitivity, we measured glucose turnover in healthy subjects during infusion of insulin at rates of 0.25, 0.6, and 2.0 mU.kg-1.min-1. Turnover was calculated using Steele's traditional NSS equations [fixed-effective volume (pV) method] as well as with methods [radioactive infused glucose (hot-GINF) or variable pV] designed to minimize NSS error. In contrast to the fixed-pV method, both the hot-GINF and variable-pV methods indicated that several hours were required for suppression of hepatic glucose release at all insulin concentrations and that small increases in plasma insulin (approximately 100 pmol/l) had comparable effects on glucose disappearance and hepatic glucose release. Nevertheless, despite these differences, when turnover during the final hour of the insulin infusions was plotted vs. the prevailing insulin concentration, all three methods yielded similar insulin dose-response curves for suppression of hepatic glucose release. Thus despite previous errors in measurement of glucose turnover, the widely accepted belief that the human liver is exquisitely sensitive to small changes in insulin is correct.

This article has been cited by other articles:

				R. L. Prigeon, S. Quddusi, B. Paty, and D. A. D'Alessio Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E701 - E707. [Abstract] [Full Text] [PDF]

				R. E. Van Pelt, W. S. Gozansky, R. S. Schwartz, and W. M. Kohrt Intravenous estrogens increase insulin clearance and action in postmenopausal women Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E311 - E317. [Abstract] [Full Text] [PDF]

				T. Utriainen, S. Lovisatti, S. Makimattila, A. Bertoldo, S. Weintraub, R. DeFronzo, C. Cobelli, and H. Yki-Jarvinen Direct measurement of the lumped constant for 2-deoxy-[1-14C]glucose in vivo in human skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E228 - E233. [Abstract] [Full Text] [PDF]

				A. Caumo, P. Vicini, J. J. Zachwieja, A. Avogaro, K. Yarasheski, D. M. Bier, and C. Cobelli Undermodeling affects minimal model indexes: insights from a two-compartment model Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1171 - E1193. [Abstract] [Full Text] [PDF]

				E. Cersosimo, P. Garlick, and J. Ferretti Insulin regulation of renal glucose metabolism in humans Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E78 - E84. [Abstract] [Full Text] [PDF]

				J. O. Nygren, A. Thorell, M. Soop, S. Efendic, K. Brismar, F. Karpe, K. S. Nair, and O. Ljungqvist Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E140 - E148. [Abstract] [Full Text] [PDF]

				D. K. Sindelar, C. A. Chu, D. W. Neal, and A. D. Cherrington Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E972 - E980. [Abstract] [Full Text] [PDF]